/Companies

Aikium

Founded 2022 · 7 employees on LinkedIn · 4 known investors

Find your way into Aikium

Sign up to see every warm intro you have to Aikium

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aikium team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels. The company focuses on drug discovery for parts of the human proteome that conventional antibodies and small molecules cannot address.

Founders & leadership

Aikium was founded in 2022 by Eswar I and Venkatesh Mysore.

EI
Eswar IFounder
VMVenkatesh Mysore
Venkatesh MysoreCo-founder and CTO2024–2026
DE
Dr. Eswar IyerCEO | Head of Synthetic Biology
MTMichael Tolentino
Michael TolentinoChief Development Officer
DS
Dr. Shankar ShastryVice President | Head of Protein Sciences

Investors · 4

Related companies · 4

Companies working in the same space as Aikium.

Frequently asked questions

What does Aikium do?
Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels. The company focuses on drug discovery for parts of the human proteome that conventional antibodies and small molecules cannot address.
Who founded Aikium?
Aikium was founded by Eswar I, Venkatesh Mysore in 2022.
Who are Aikium's investors?
Aikium's investors include Aligned Health Ventures, Bantam Group, Civilization Ventures Management, Llc, Fellows.